Lung Atypical Carcinoid Tumor
NCI Definition: A carcinoid tumor of the lung showing focal necrotic changes or a number of mitotic figures between 2 and 10/10 high power fields. 
Lung atypical carcinoid tumors most frequently harbor alterations in MEN1, KMT2D, CCND1, and ATM .
MEN1 Mutation, KMT2D Mutation, and CCND1 Amplification are the most common alterations in lung atypical carcinoid tumor .
There is 1 clinical trial for lung atypical carcinoid tumor, of which 1 is open and 0 are completed or closed. Of the trial that contains lung atypical carcinoid tumor as an inclusion criterion, 1 is phase 2 (1 open).
Atezolizumab and cabozantinib are the most common interventions in lung atypical carcinoid tumor clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.